Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients

Breast Cancer Research

Volumn 10, Issue 4, 2008, Pages

  Deng, Glenn ^a   Herrler, Michael ^a   Burgess, David ^a   Manna, Edward ^b   Krag, David ^b   Burke, Julian F ^c  

^a NEC Corporation of America   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c Genetix Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; KERATIN; TUMOR ANTIGEN; TUMOR ASSOCIATED ANTIGEN GA733; TUMOR MARKER; TUMOR-ASSOCIATED ANTIGEN GA733;

ARTICLE; BIOSYNTHESIS; BREAST TUMOR; CELL NUCLEUS; FEMALE; HUMAN; IMAGE PROCESSING; LABORATORY DIAGNOSIS; METABOLISM; METASTASIS; METHODOLOGY; ONCOLOGY; PATHOLOGY; REPRODUCIBILITY; TUMOR CELL LINE; TUMOR EMBOLISM;

ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; CELL NUCLEUS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KERATINS; MEDICAL ONCOLOGY; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 65849240762     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2131     Document Type: Article

References (59)

1. Nagrath S, Sequit LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M. Isolation of rare circulating tumor cells in cancer patients by microchip technology. Nature 2007, 450:1235-1239. 10.1038/nature06385, 18097410.
2. Fehm T, Solomayer EF, Meng S, Tucker T, Lane N, Wang J, Gebauer G. Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells. Cytotherapy 2005, 7:171-185. 10.1080/14653240510027082, 16040397.
3. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004, 4:448-456. 10.1038/nrc1370, 15170447.
4. Braun S, Pantel K, Mueller P, Janni W, Hepp F, Kentenich CRM, Gastroph S, Wischnik A, Dimpfl T, Kindermann G, Riethmuller G, Schlimok G. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000, 342:525-533. 10.1056/NEJM200002243420801, 10684910.
5. Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G, Diel IJ, Gerber B, Gebauer G, Pierga JY, Marth C, Oruzio D, Wiedswang G, Solomayer EF, Kundt G, Strobl B, Fehm T, Wong GYC, Bliss J, Vincent-Solomon A, Pantel K. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 2005, 353:793-802. 10.1056/NEJMoa050434, 16120859.
6. Meng S, Tripathy D, Shete S, Ashfaq R, Saboorian H, Haley B, Frenkel E, Euhus D, Leitch M, Osborne C, Clifford E, Perkins S, Beitsch P, Khan A, Morrison L, Herlyn D, Terstappen LWMM, Lane N, Wang J, Uhr J. uPAR and HER-2 gene status in individual breast cancer cells from blood and tissues. Proc Natl Acad Sci USA 2006, 103:17361-17365. 1838539, 17079488, 10.1073/pnas.0608113103.
7. Christofanilli M, Mendelsohn J. Circulating tumor cells in breast cancer: Advanced tools for "tailored" therapy?. Proc Natl Acad Sci USA 2006, 103:17073-17074. 1859890, 17090687, 10.1073/pnas.0608651103.
8. Borgen E, Naume B, Nesland JM, Kvalheim G, Beiske K, Fodstad O, Diel I, Solomayer EF, Theocharous P, Coombes RC, Smith BM, Wunder E, Marolleau JP, Garcia J, Pantel K. Standardization of the immunocytochemical detection of cancer cells in BM and blood. I. Establishment of objective criteria for the evaluation of immunostained cells. Cytotherapy 1999, 5:377-388.
9. Hsieh HB, Marrinucci D, Bethel K, Curry DN, Humphrey M, Krivacic RT, Kroener J, Kroener L, Ladanyi A, Lazarus N, Kuhn P, Bruce RH, Nieva J. High speed detection of circulating tumor cells. Biosens Bioelectron 2006, 21:1893-1899. 10.1016/j.bios.2005.12.024, 16464570.
10. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AGJ, Uhr JW, Terstappen LWMM. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004, 10:6897-6904. 10.1158/1078-0432.CCR-04-0378, 15501967.
11. Tibbe AGJ, Miller MC, Terstappen LWMM. Statistical considerations for enumeration of circulating tumor cells. Cytometry A 2007, 71:154-162.
12. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LWMM, Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351:781-791. 10.1056/NEJMoa040766, 15317891.
13. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN, Terstappen LWMM. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 2005, 23:1420-1430. 10.1200/JCO.2005.08.140, 15735118.
14. Riethdorf S, Fritsche H, Muller V, Rau T, Schindlebeck C, Rack B, Janni W, Coith C, Beck K, Janicke F, Jackson S, Gornet T, Cristofanilli M, Pantel K. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearch system. Clin Cancer Res 2007, 13:920-928. 10.1158/1078-0432.CCR-06-1695, 17289886.
15. Thurm H, Ebel S, Kentenich C, Hemsen A, Riethdorf S, Coith C, Wallwiener D, Braun S, Oberhoff C, Janicke F, Pantel K. Rare expression of epithelial cell adhesion molecule on residual micrometastatic breast cancer cells after adjuvant chemotherapy. Clin Cancer Res 2003, 9:2598-2604.
16. Woelfle U, Cloos J, Sauter G, Riethdorf L, Janicke F, van Diest P, Brakenhoff R, Pantel K. Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 2003, 63:5679-5684.
17. Woelfle U, Sauter G, Santjer S, Brakenhoff R, Pantel K. Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer. Clin Cancer Res 2004, 10:2670-2674. 10.1158/1078-0432.CCR-03-0114, 15102669.
18. Willipinski-Stapelfeldt B, Riethdorf S, Assmann V, Woelfle U, Rau T, Sauter G, Heukeshoven J, Pantel K. Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells. Clin Cancer Res 2005, 11:8006-8014. 10.1158/1078-0432.CCR-05-0632, 16299229.
19. Went PTH, Lugli A, Meier S, Bundi M, Mirlacher M, Sauter G, Dirnhofer S. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004, 35:122-128. 10.1016/j.humpath.2003.08.026, 14745734.
20. Krag DN, Kusminsky R, Manna E, Ambaye A, Weaver DL, Harlow SP, Covelli M, Stanley MA, McCahill L, Ittleman F, Leavitt B, Krag M. The detection of isolated tumor cells in bone marrow comparing bright-field immunocytochemistry and multicolor immunofluorescence. Ann Surg Oncol 2005, 12:753-760. 10.1245/ASO.2005.12.004, 16079954.
21. Zeidman I. The fate of circulating tumor cells. I. Passage of cells through capillaries. Cancer Res 1961, 21:38-39.
22. Fidler IJ. Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst 1970, 45:773-782.
23. Brandt B, Junker R, Griwatz C, Heidl S, Brinkmann O, Semjonow A, Assmann G, Zanker KS. Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res 1996, 56:4556-4561.
24. Schmidt H, De Angelis G, Bettendorf O, Eltze E, Semjonow A, Knichwitz G, Brandt B. Frequent detection and immunophenotyping of prostate-derived cell clusters in the peripheral blood of prostate cancer patients. Intl J of Biological Markers 2004, 19:93-99. 15255540.
25. Muller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A, Janicke F, Pantel K. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res 2005, 11:3678-3685. 10.1158/1078-0432.CCR-04-2469, 15897564.
26. Liberti PA, Rao CG, Terstappen LWM. Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood. J Magnetism Magnetic Materials 2001, 225:301-307.
27. Wiedswang G, Borgen E, Schirmer C, Karesen R, Kvalheim G, Nesland JM, Naume B. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. Intl J Cancer 2006, 118:2013-2019. 16287086, 10.1002/ijc.21576.
28. Balic M, Dandachi N, Hofmann G, Hofmann G, Samonigg H, Loibner H, Obwaller A, Kooi A, Tibbe AGJ, Doyle GV, Terstappen LWMM, Bauernhofer T. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry B (Clin Cytom) 2005, 68:25-30. 1614278, 10.1002/cyto.b.20065.
29. Baker MK, Mikhitarian K, Osta W, Callahan K, Hoda R, Brescia F, Kneuper-Hall R, Mitas M, Cole DJ, Gillanders WE. Molecular detection of breast cancer cells in the peripheral blood of advanced-stage breast cancer patients using multimarker real-time reverse transcription-polymerase chain reaction and a novel porous barrier density gradient centrifugation technology. Clin Cancer Res 2003, 9:4865-4871.
30. Gertler R, Rosenberg R, Fuehrer K, Dahm M, Nekarda H, Siewert JR. Detection of circulating tumor cells in blood using an optimized density gradient centrifugation. Recent Results Cancer Res 2003, 162:149-155.
31. Rosenberg R, Gertler R, Friederichs J, Fuehrer K, Dahm M, Phelps R, Thorban S, Nekarda H, Siewert JR. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood. Cytometry 2002, 49:150-158. 10.1002/cyto.10161, 12454978.
32. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LWMM, Uhr JW. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998, 95:4589-4594. 22534, 9539782, 10.1073/pnas.95.8.4589.
33. Witzig TE, Bossy B, Kimlinger rant C, Donohue J, Suman VJ, Harrington D, Torre-Bueno J, Bauer KD. Detection of circulating cytokeratin-positive cells in the blood of breast cancer patients using immunomagnetic enrichment and digital microscopy. Clin Cancer Res 2002, 8:1085-1091.
34. Krag DN, Ashikaga T, Moss TJ, Kusminsky RE, Feldman S, Carp NZ, Moffat FL, Beisch PD, Frazier TG, Gaskin TA, Shook JW, Harlow SP, Weaver DL. Breast cancer cells in the blood: a pilot study. Breast J 1999, 5:354-358. 10.1046/j.1524-4741.1999.99016.x, 11348313.
35. Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Perkins S, Beitsch P, Khan A, Euhus D, Osborne C, Frenkel E, Hoover S, Leitch M, Clifford E, Vitetta E, Morrison L, Herlyn D, Terstappen LWMM, Fleming T, Fehm T, Tucker T, Lane N, Wang J, Uhr J. HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci USA 2004, 101:9393-9398. 438987, 15194824, 10.1073/pnas.0402993101.
36. Griwatz C, Brandt B, Assmann G, Zanker KS. An immunological enrichment method for epithelial cells from peripheral blood. J Immunol Methods 1995, 183:251-265. 10.1016/0022-1759(95)00063-G, 7602148.
37. Brooimans RA, de Leeuw N, Bontenbal M, Gratama JW. An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies. J Biol Regul Homeost Agents 2005, 19:84-91.
38. Choesmel V, Anract P, Hoifodt H, Thiery JP, Blin N. A relevant immunomagnetic assay to detect and characterize epithelial cell adhesion molecule-positive cells in bone marrow from patients with breast carcinoma: immunomagnetic purification of micrometastases. Cancer 2004, 101:693-703. 10.1002/cncr.20391, 15305398.
39. Hu XC, Wang Y, Shi DR, Loo TY, Chow LWC. Immunomagnetic tumor cell enrichment is promising in detecting circulating breast cancer cells. Oncology 2003, 64:160-165. 10.1159/000067776, 12566914.
40. Wang ZP, Eisenberger MA, Carducci MA, Partin AW, Scher HI, Ts'o POP. Identification and characterization of circulating prostate carcinoma cells. Cancer 2000, 88:2787-2795. 10.1002/1097-0142(20000615)88:12<2787::AID-CNCR18>3.0.CO;2-2, 10870062.
41. Meye A, Bilkenroth U, Schmidt U, Fussel S, Robel K, Melchior AM, Blumke K, Pinkert D, Bartel F, Linne C, Taubert H, Wirth MP. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol. Int J Oncol 2002, 21:521-530.
42. Taubert H, Blumke K, Bilkenroth U, Meye A, Kutz A, Bartel F, Lautenschlager C, Ulbrich EJ, Nass N, Holzhausen HJ, Koelbl H, Lebrecht A. Detection of disseminated tumor cells in peripheral blood of patients with breast cancer: correlation to nodal status and occurrence of metastases. Gynecol Onco 2004, 92:256-261. 14751168, 10.1016/j.ygyno.2003.09.009.
43. Allan AL, Vantyghem SA, Tuck AB, Chambers AF, Chin-Yee IH, Keeney M. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry. Cytometry A 2005, 65:4-14.
44. Cruz I, Ciudad J, Cruz JJ, Ramos M, Gomez-Alonso A, Adansa JC, Rodriguez C, Orfao A. Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples. Am J Clin Pathol 2005, 123:66-74. 10.1309/WP3QWKVJFYDHHXQD, 15762281.
45. Kahn HJ, Presta A, Yang LY, Blondal J, Trudeau M, Lickley L, Holloway C, McCready DR, Maclean D, Marks A. Enumeration of circulating tumor cells in the blood of breast cancer patients after filtration enrichment: correlation with disease stage. Breast Cancer Res Treat 2004, 86:237-247. 10.1023/B:BREA.0000036897.92513.72, 15567940.
46. Vona G, Sabile A, Louha M, Sitruk V, Romana S, Schutze K, Capron F, Franco D, Pazzagli M, Vekemans M, Lacour B, Brechot C, Paterlini-Brechot P. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 2000, 156:57-63. 1868645, 10623654.
47. Wong NS, Kahn HJ, Zhang L, Oldfield S, Yang LY, Marks A, Trudeau ME. Prognostic significance of circulating tumor cells enumerated after filtration enrichment in early and metastatic breast cancer patients. Breast Cancer Res Treat 2006, 99:63-69. 10.1007/s10549-006-9181-4, 16541316.
48. Rao CG, Chianese D, Doyle GV, Miller MC, Russell T, Sanders RA, Terstappen LW. Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors. Intl J Oncol 2005, 27:49-57. 15942643.
49. Mehes G, Witt A, Kubista E, Ambros PF. Circulating breast cancer cells are frequently apoptotic. Am J Pathol 2001, 159:17-20. 1850424, 11438448.
50. Schmidt H, DeAngelis G, Eltze E, Gockel I, Semjonow A, Brandt B. Asynchronous growth of prostate cancer is reflected by circulating tumor cells delivered from distinct, even small foci, harboring loss of heterozygosity of the PTEN gene. Cancer Res 2006, 66:8959-8965. 10.1158/0008-5472.CAN-06-1722, 16982734.
51. Pachmann K, Camara O, Kavallaris A, Schneider U, Schunemann S, Hoffen K. Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring. Breast Cancer Res 2005, 7:R975-R979. 1410761, 16280045, 10.1186/bcr1328.
52. Smirnov DA, Zweitzig DR, Foulk BW, Miller MC, Doyle GV, Pienta KJ, Meropol NJ, Meiner LM, Cohen SJ, Moreno JG, Connelly MC, Terstappen LWMM, O'Hara SM. Global gene expression profiling of circulating tumor cells. Cancer Res 2005, 65:4993-4997. 10.1158/0008-5472.CAN-04-4330, 15958538.
53. Smirnov DA, Foulk BW, Doyle GV, Connelly MC, Terstappen LWMM, O'Hara SM. Global expression profiling of circulating endothelial cells in patients with metastatic carcinomas. Cancer Res 2006, 66:2918-2922. 10.1158/0008-5472.CAN-05-4003, 16540638.
54. Ge M, Shi D, Wu Q, Wang M, Li L. Fluctuation of circulating tumor cells in patients with lung cancer by real-time fluorescent quantitative-PCR approach before and after radiotherapy. J Cancer Res Ther 2005, 4:221-226. 17998657.
55. Lin JC, Chen KY, Wang WY, Jan JS, Liang WM, Wei YH. Evaluation of cytokeratin-19 mRNA as a tumor marker in the peripheral blood of nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy. Int J Cancer 2002, 97:548-553. 10.1002/ijc.10075, 11802221.
56. Pelkey TJ, Frierson HF, Bruns DE. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 1996, 42:1369-1381.
57. Sabbatini R, Federico M, Morselli M, Depenni R, Cagossi K, Luppi M, Torelli G, Silingardi V. Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy. J Clin Oncol 2000, 18:1914-1920.
58. Uchikura K, Takao S, Nakajo A, Miyazono F, Nakashima S, Tokuda K, Matsumoto M, Shinchi H, Natsugoe S, Aikou T. Intraoperative molecular detection of circulating tumor cells by reverse transcription-polymerase chain reaction in patients with biliary-pancreatic cancer is associated with hematogenous metastasis. Ann Surg Oncol 2002, 9:364-370.
59. O'Hara SM, Moreno JG, Zeitzig DR, Gross S, Gomella LG, Terstappen LWMM. Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer. Clin Chem 2004, 50:826-835. 10.1373/clinchem.2003.028563, 14988224.